Literature DB >> 2325432

Forskolin activation of adenylate cyclase in rat myocardium with age: effects of guanine nucleotide analogs.

P J Scarpace1.   

Abstract

Beta-adrenergic and post-receptor activation of adenylate cyclase decreases with age in the rat myocardium. Forskolin-stimulated adenylate cyclase activity decreases with age to the same extent as NaF or isoproterenol stimulation, suggesting that a loss of catalytic unit activity accounts for the loss of activity with age. However, recent evidence suggests that there are both a guanine nucleotide-dependent and independent component of forskolin activation. We assessed the possible role of each of these components with age by measuring forskolin dose-response stimulation of adenylate cyclase activity in the presence and absence of guanosine 5'-O-(2-thiodiphosphate) (GDP-beta S) and beta,gamma-imidoguanine 5'-triphosphate (Gpp(NH)p) in myocardial membranes from F-344 rats of 3, 12, and 24 months of age. Maximal forskolin stimulation of adenylate cyclase was least in the 24- (121 +/- 21 pmol cAMP/min/mg) as compared with either the 12- (212 +/- 29) or 3- (190 +/- 19) month-old rats. The presence of GDP-beta S had no effect on either the EC50 or maximum activity, and the age-related decline persisted. Gpp(NH)p plus isoproterenol enhanced forskolin activation but the effect was additive and not synergistic. There was no effect on the EC50, and the maximum activity was least in the 24-month-old rats. These data reconfirm the loss of catalytic unit activity with age and indicate that the reduced activity with age is independent of the presence or absence of activated G-protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2325432     DOI: 10.1016/0047-6374(90)90122-v

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  7 in total

Review 1.  Age-associated alterations in calcium current and its modulation in cardiac myocytes.

Authors:  Y Y Zhou; E G Lakatta; R P Xiao
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 3.923

Review 2.  Beta-adrenergic function in aging. Basic mechanisms and clinical implications.

Authors:  P J Scarpace; N Tumer; S L Mader
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

3.  Effect of aging on rat skeletal muscle beta-AR function in male Fischer 344 x brown Norway rats.

Authors:  L M Larkin; J B Halter; M A Supiano
Journal:  Am J Physiol       Date:  1996-02

Review 4.  Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons.

Authors:  Edward G Lakatta
Journal:  Heart Fail Rev       Date:  2002-01       Impact factor: 4.214

5.  Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases.

Authors:  R P Xiao; E D Tomhave; D J Wang; X Ji; M O Boluyt; H Cheng; E G Lakatta; W J Koch
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

6.  Assessment of the Effects of Age, Gender, and Exercise Training on the Cardiac Sympathetic Nervous System Using Positron Emission Tomography Imaging.

Authors:  Gwen M Bernacki; Samira Bahrainy; James H Caldwell; Wayne C Levy; Jeanne M Link; John R Stratton
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-03-08       Impact factor: 6.053

7.  Adrenergic stimulated skeletal muscle glycogenolysis in perfused hindlimbs of young and old male Fischer 344 rats.

Authors:  L M Larkin; B A Horwitz; K C Eiffert; R B McDonald
Journal:  Am J Physiol       Date:  1994-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.